Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying C Henderson

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Archives of Otolaryngology--Head & Neck Surgery|April 22, 2009
Inhibition of the growth of papillary thyroid carcinoma cells by CI-1040Ying C Henderson, Soon-Hyun Ahn, Gary L Clayman
Archives of Otolaryngology--Head & Neck Surgery|August 22, 2007
Differential responses of human papillary thyroid cancer cell lines carrying the RET/PTC1 rearrangement or a BRAF mutation to MEK1/2 inhibitorsYing C Henderson, Mitchell J Fredrick, Gary L Clayman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangementYing C Henderson, Soon-Hyun Ahn, Ya'an Kang, et al.
Molecular Cancer Therapeutics|July 1, 2010
MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivoYing C Henderson, Yunyun Chen, Mitchell J Frederick, et al.
Head & Neck|December 25, 2008
Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinomaAbhijit Mazumdar, Ying C Henderson, Adel K El-Naggar, et al.
The Journal of Clinical Endocrinology and Metabolism|December 5, 2013
Detection of thyroid cancer stem cells in papillary thyroid carcinomaSoon-Hyun Ahn, Ying C Henderson, Michelle D Williams, et al.
DNA and Cell Biology|November 17, 2007
LBP-1b, LBP-9, and LBP-32/MGR detected in syncytiotrophoblasts from first-trimester human placental tissue and their transcriptional regulationYing C Henderson, Mitchell J Frederick, Mary T Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2015
Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTCJonathan R George, Ying C Henderson, Michelle D Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinomaYing C Henderson, Thomas D Shellenberger, Michelle D Williams, et al.
Head & Neck|June 5, 2013
Src inhibitors in suppression of papillary thyroid carcinoma growthYing C Henderson, Rafael Toro-Serra, Yunyun Chen, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Archives of Otolaryngology--Head & Neck Surgery|April 22, 2009
Inhibition of the growth of papillary thyroid carcinoma cells by CI-1040Ying C Henderson, Soon-Hyun Ahn, Gary L Clayman
Archives of Otolaryngology--Head & Neck Surgery|August 22, 2007
Differential responses of human papillary thyroid cancer cell lines carrying the RET/PTC1 rearrangement or a BRAF mutation to MEK1/2 inhibitorsYing C Henderson, Mitchell J Fredrick, Gary L Clayman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangementYing C Henderson, Soon-Hyun Ahn, Ya'an Kang, et al.
Molecular Cancer Therapeutics|July 1, 2010
MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivoYing C Henderson, Yunyun Chen, Mitchell J Frederick, et al.
Head & Neck|December 25, 2008
Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinomaAbhijit Mazumdar, Ying C Henderson, Adel K El-Naggar, et al.
The Journal of Clinical Endocrinology and Metabolism|December 5, 2013
Detection of thyroid cancer stem cells in papillary thyroid carcinomaSoon-Hyun Ahn, Ying C Henderson, Michelle D Williams, et al.
DNA and Cell Biology|November 17, 2007
LBP-1b, LBP-9, and LBP-32/MGR detected in syncytiotrophoblasts from first-trimester human placental tissue and their transcriptional regulationYing C Henderson, Mitchell J Frederick, Mary T Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2015
Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTCJonathan R George, Ying C Henderson, Michelle D Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinomaYing C Henderson, Thomas D Shellenberger, Michelle D Williams, et al.
Head & Neck|June 5, 2013
Src inhibitors in suppression of papillary thyroid carcinoma growthYing C Henderson, Rafael Toro-Serra, Yunyun Chen, et al.
Pageof 3